HARMONi-2

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

HARMONi-2

Mar 11, 2025, 13:12 | Science

Patrick Forde: PD-1 VEGF bispecific doubles PFS in 1st line advanced NSCLC

Patrick Forde, Professor at Johns Hopkins University and Co-Director of the Division of Upper Aerodigestive…

Mar 11, 2025, 10:45 | Oncolibrary

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

The HARMONi-2 study, a randomized phase 3 trial conducted in China, compared ivonescimab with pembrolizumab…

Sep 9, 2024, 15:30 | Societies

25 Posts Not To Miss from Day 2 of WCLC24

The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…

Aug 12, 2024, 14:02 | Blog

Stephen Liu: WCLC24 abstract titles released

Stephen Liu shared a post on X: "WCLC24 abstract titles released! Don't miss the plenary…

All: 4 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023